- Home
- / Turnstone Biologics
Turnstone Biologics
Stock Price
$0.5
2024-10-29
Market Capitalization
$11.6 M
2024-10-29
Revenue
$19.3 M
FY, 2023
Turnstone Biologics Summary
Company Summary
- Overview
- Turnstone Biologics is an immuno-oncology company. It develops viral immunotherapies and oncolytic viruses for cancer treatment.
- Type
- Public
- Status
- Active
- Founded
- 2015
- HQ
- San Diego, CA, US | view all locations
- Website
- https://turnstonebio.com
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Stewart Abbot, Chief Scientific Officer
Venkat Ramanan, Chief Financial Officer
Saryah Azmat, Chief Business Officer
LocationsView all
2 locations detected
San Diego, CA HQ
United States
9310 Athena Cir #300, La Jolla
Ottawa, ON
Canada
12 York St 3rd Floor
Turnstone Biologics Financials
Summary Financials
- Net income (Q2, 2025)
- ($5.5M)
- Cash (Q2, 2025)
- $16.7M
- EBIT (Q2, 2025)
- ($5.6M)
- Enterprise value
- ($4.3M)